News

Jasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
(92%) enrolled in the 180mg cohort achieved a complete response. 12 of 12 participants (100%) in the 180mg cohort achieved a clinical response. Tryptase leve ...
Translational Data Illustrate A Mechanism Of Greater Potency With Verekitug, A Novel Antibody Antagonist Of The TSLP Receptor
Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for gr ...